Panacea Biotech
- All
- News
- Videos
-
Dengue Vaccine In The Works, Phase-3 Trial Soon: Top Medical Body
The phase-3 trial for a dengue vaccine developed by Panacea Biotech is likely to begin in a few months, a senior official said as quoted by news agency ANI.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
Panacea Biotech Falls After Adar Poonawalla Offloads Stake For Rs 118 Crore
Panacea Biotech Share Price: On Tuesday, Panacea Biotech opened on the BSE at Rs 389, swinging to anan intra day high of Rs 393.15 and an intra day low of Rs 372.50, so far.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
-
Panacea Biotec To Partner With US-Based Refana Inc For COVID-19 Vaccine
Biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for COVID-19.
-
Panacea Biotech Raises Supply Of Life Saving Drug, Stocks Soar
Panacea Biotech shares surged as much as 9 per cent on Tuesday after the drug firm saidit has increased availability of life saving drug Cilamin250 capsules.
-
Government Nod to 15 FDI Plans; Cabinet to Consider HDFC Proposal
The Finance Ministry on Friday said it has cleared 15 FDI applications, including that of Panacea Biotech and Sanofi-Synthelabo (India), and recommended HDFC Bank's proposal to hike foreign holding to the Cabinet Committee on Economic Affairs (CCEA) for consideration.
-
Dengue Vaccine In The Works, Phase-3 Trial Soon: Top Medical Body
The phase-3 trial for a dengue vaccine developed by Panacea Biotech is likely to begin in a few months, a senior official said as quoted by news agency ANI.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
Panacea Biotech Falls After Adar Poonawalla Offloads Stake For Rs 118 Crore
Panacea Biotech Share Price: On Tuesday, Panacea Biotech opened on the BSE at Rs 389, swinging to anan intra day high of Rs 393.15 and an intra day low of Rs 372.50, so far.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
-
Panacea Biotec To Partner With US-Based Refana Inc For COVID-19 Vaccine
Biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for COVID-19.
-
Panacea Biotech Raises Supply Of Life Saving Drug, Stocks Soar
Panacea Biotech shares surged as much as 9 per cent on Tuesday after the drug firm saidit has increased availability of life saving drug Cilamin250 capsules.
-
Government Nod to 15 FDI Plans; Cabinet to Consider HDFC Proposal
The Finance Ministry on Friday said it has cleared 15 FDI applications, including that of Panacea Biotech and Sanofi-Synthelabo (India), and recommended HDFC Bank's proposal to hike foreign holding to the Cabinet Committee on Economic Affairs (CCEA) for consideration.
